OOIR: Observatory of International Research

Papers

(The H4-Index of Progress in Retinal and Eye Research is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
In vivo application of base and prime editing to treat inherited retinal diseases	290
The neuroimmune interface in retinal regeneration	224
Cell identity changes in ocular surface Epithelia	222
Immunological aspects of RPE cell transplantation	217
Non-vasogenic cystoid maculopathies	202
Animal models for the evaluation of retinal stem cell therapies	152
Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO)	134
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions	130
Editorial Board	128
Mitophagy in the retina: Viewing mitochondrial homeostasis through a new lens	123
Consensus and controversies in the science of endophthalmitis management: Basic research and clinical perspectives	115
Structure and function of ABCA4 and its role in the visual cycle and Stargardt macular degeneration	106
The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas	104
Corneal stromal repair and regeneration	92
Central serous chorioretinopathy: An evidence-based treatment guideline	90
Editorial Board	89
Etiopathogenesis of primary acquired nasolacrimal duct obstruction (PANDO)	88
Gene-independent therapeutic interventions to maintain and restore light sensitivity in degenerating photoreceptors	86
Risk factors, clinical features and treatment of Behçet's disease uveitis	84
Myocilin misfolding and glaucoma: A 20-year update	84
A paradigm shift in retinal detachment repair: The concept of integrity	83
Squishy matters – Corneal mechanobiology in health and disease	82
Homeostatic plasticity in the retina	81
Photocoagulation for retinal vein occlusion	79
The endoplasmic reticulum: Homeostasis and crosstalk in retinal health and disease	75

Cell fate decisions, transcription factors and signaling during early retinal development	75
Uncoupling proteins in the mitochondrial defense against oxidative stress	74
Multiple gene therapy as a tool for regulating the expression of molecules involved in neovascular age-related macular degeneration	72
Editorial Board	72
The retinal pigmentation pathway in human albinism: Not so black and white	65
Patient derived stem cells for discovery and validation of novel pathogenic variants in inherited retinal disease	65
Protection against corneal hyperosmolarity with soft-contact-lens wear	65
Genetic Architecture of Congenital Cataracts: Correlation of Pathogenic Variants with Morphology and Clinical Outcomes	64
How gut microbiota may impact ocular surface homeostasis and related disorders	64
The vital role for nitric oxide in intraocular pressure homeostasis	63
RNA-targeting strategies as a platform for ocular gene therapy	62
Photoreceptor cells and RPE contribute to the development of diabetic retinopathy	61
Approaches for corneal endothelium regenerative medicine	61
Corrigendum to “Optical coherence tomography in the management of diabetic macular oedema” [Prog. Retin. Eye Res. 98 (2024) 101220]	61
Cellular component transfer between photoreceptor cells of the retina	60
Exploring single-cell RNA sequencing as a decision-making tool in the clinical management of Fuchs’ endothelial corneal dystrophy	59
Targeting inflammasomes and pyroptosis in retinal diseases—molecular mechanisms and future perspectives	58
Clinical vision and molecular loss: Integrating visual psychophysics with molecular genetics reveals key details of normal and abnormal visual processing	58
Rhodopsin, light-sensor of vision	58
Optical coherence tomography angiography in diabetic retinopathy	57
Identification of novel biomarkers for retinopathy of prematurity in preterm infants by use of innovative technologies and artificial intelligence	57
Editorial Board	56
Retinal pigment epithelium 65 kDa protein (RPE65): An update	54
Female carriers of X-linked inherited retinal diseases – Genetics, diagnosis, and potential therapies	54
Genetic therapies and potential therapeutic applications of CRISPR activators in the eye	54
The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems	54
Pseudoxanthoma elasticum – Genetics, pathophysiology, and clinical presentation	53
Regulation of lens water content: Effects on the physiological optics of the lens	52